GlaxoSmithKline Pharmaceuticals (BOM:500660) EV-to-Revenue : 11.64 (As of Jun. 07, 2024)

GlaxoSmithKline Pharmaceuticals EV-to-Revenue Chart

GlaxoSmithKline Pharmaceuticals Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
EV-to-Revenue		Get a 7-Day Free Trial					6.28	8.03	7.75	6.44	9.03

GlaxoSmithKline Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															6.44	7.44	7.45	9.78	9.03

Competitive Comparison of GlaxoSmithKline Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's EV-to-Revenue falls into.

GlaxoSmithKline Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

GlaxoSmithKline Pharmaceuticals's EV-to-Revenue for today is calculated as:

GlaxoSmithKline Pharmaceuticals's current Enterprise Value is ₹400,602 Mil.
GlaxoSmithKline Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹34,418 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline Pharmaceuticals  (BOM:500660) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

GlaxoSmithKline Pharmaceuticals's PS Ratiofor today is calculated as:

GlaxoSmithKline Pharmaceuticals's share price for today is ₹2473.25.
GlaxoSmithKline Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹203.18.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Pharmaceuticals (BOM:500660) Business Description